Using oncolytic viral therapy to target the tumour microenvironment in chromosomally unstable cancers

The cancer treatment landscape has been transformed by the success of immunotherapies over the past decade. However, most patients still receive no benefit from this approach, due to tumour-mediated immunosuppressive mechanisms. One of these immunosuppressive strategies involves cancer-associated fibroblasts - these are otherwise normal stromal…